Amara, US
Ashok Amara, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150213484 | SYSTEM AND METHOD FOR TRACKING RELATED EVENTS - A system and method for tracking conversion events. Tracking events are stored in a history table of a database, wherein the tracking events include conversion events associated with predetermined actions performed by users on websites, and wherein a respective tracking event is associated with a respective user and a respective website. A conversion event stored in the history table of the database is identified, wherein the conversion event is associated with a predetermined action performed by a user on a website. A set of tracking events is retrieved from the history table that are associated with the website, that are associated with the user, and that occurred prior in time to the conversion event. In response to a request from a user request, a report is generated for display on a client computer system, wherein the report includes the set of tracking events and the conversion event. | 07-30-2015 |
Ashok Babu Amara, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20090157898 | Generic Format for Efficient Transfer of Data - Methods, systems and apparatus, including computer program products, for transferring, receiving, and storing multiple element data in a string of characters. Multiple data elements are sent in a string of delimited characters and have respective project identifiers, data types, and index numbers used to extract and store the data elements at a receiving computer. | 06-18-2009 |
20110307515 | Conversion Path Performance Measures And Reports - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for providing conversion path performance measures and reports. In one aspect, user interaction data are obtained, were the user interaction data specify user interactions for a plurality of conversions. User interactions that are associated with each conversion are selected from the user interaction data, where the associated user interactions for each conversion are user interactions with a converting user during the conversion cycle for the conversion. Using the user interaction data for the selected user interactions, a quantity of user interactions that are associated with each conversion and occurred during the conversion cycle for the conversion are determined. In turn, conversion path performance measures are computed and reports specifying the conversion path performance measures are generated. | 12-15-2011 |
Ashok Babu Amara, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20130297775 | PERSIST AND PROCESS ANALYTICS DATA DIMENSIONS FOR SERVER-SIDE SESSIONIZATION - The subject technology provides configurations for propagating information from an initial analytics tracking data communication to subsequent analytics tracking data communications at an analytics server. In one example, the subject technology receives an analytics tracking data communication. The subject technology determines if the received analytics tracking data communication includes state changing information based on analytics tracking data included in the analytics tracking data communication. The subject technology then determines one or more attributes for propagating to subsequent analytics tracking data if the analytics tracking data communication includes state changing information. The state changing information are stored as one or more of the determined one or more attributes. The subject technology stores the analytics tracking data including the determined one or more attributes. | 11-07-2013 |
20130297777 | SERVER-SIDE CONFIGURATION DRIVEN SESSIONIZATION TO PROVIDE CONSISTENT BUSINESS LOGIC - The subject technology provides configurations for determining resource configuration information for applying to analytics tracking data. Resource information is determined based on analytics tracking data from an analytics tracking data communication in which the resource information includes a corresponding resource associated with a source, and the analytics tracking data includes data for tracking an activity associated with the source. The subject technology determines resource configuration information based on the determined resource information in which the resource configuration information includes one or more attributes associated with the corresponding resource. One or more attributes are then applied from the determined resource configuration information to the analytics tracking data. | 11-07-2013 |
20130297778 | SYSTEM FOR CENTRALIZED ANALYTICS TRACKING VIA SERVER-SIDE SESSIONIZATION - The subject technology provides a session associated with web site or application traffic data. An analytics tracking data communication is received. The subject technology determines analytics tracking data from the received analytics tracking data communication in which the analytics tracking data includes data for tracking an activity associated with a web site or application and includes visitor information. A new session associated with the analytics tracking data is created if it is determined that the activity is associated with an initial visit of a unique visitor corresponding to the visitor information. The subject technology determines campaign information for populating the new session associated with the analytics tracking data. The analytics tracking data including the determined campaign information is then stored. | 11-07-2013 |
John Amara, Reading, MA US
Patent application number | Description | Published |
---|---|---|
20120029176 | Chromatography Media And Method - Adsorptive media for chromatography, particularly ion-exchange chromatography, derived from a shaped fiber. In certain embodiments, the functionalized shaped fiber presents a fibrillated or ridged structure which greatly increases the surface area of the fibers when compared to ordinary fibers. Also disclosed herein is a method to add surface pendant functional groups that provides cation-exchange or anion-exchange functionality to the high surface area fibers. This pendant functionality is useful for the ion-exchange chromatographic purification of biomolecules, such as monoclonal antibodies (mAbs). | 02-02-2012 |
20150258540 | Chromatography Media And Method - Adsorptive media for chromatography, particularly ion-exchange chromatography, derived from a shaped fiber. In certain embodiments, the functionalized shaped fiber presents a fibrillated or ridged structure which greatly increases the surface area of the fibers when compared to ordinary fibers. Also disclosed herein is a method to add surface pendant functional groups that provides cation-exchange or anion-exchange functionality to the high surface area fibers. This pendant functionality is useful for the ion-exchange chromatographic purification of biomolecules, such as monoclonal antibodies (mAbs). | 09-17-2015 |
John Amara, Billerica, MA US
Patent application number | Description | Published |
---|---|---|
20150352465 | Chromatography Media For Purifying Vaccines And Viruses - Adsorptive media for chromatography, particularly ionexchange chromatography, derived from a shaped fiber, useful for purifying viruses. In certain embodiments, the functionalized shaped fiber presents a fibrillated or ridged structure which greatly increases the surface area of the fibers when compared to ordinary fibers. Surface pendant functional groups can be added that provides ion-exchange functionality to the high surface area fibers. This pendant functionality is useful for the ion-exchange chromatographic purification of viruses, such as influenza. | 12-10-2015 |
John P. Amara, Reading, MA US
Patent application number | Description | Published |
---|---|---|
20100297556 | Coating compositions suitable for use with an overcoated photoresist - Organic coating compositions, particularly antireflective coating compositions, are provided that comprise that comprise a diene/dienophile reaction product. Preferred compositions of the invention are useful to reduce reflection of exposing radiation from a substrate back into an overcoated photoresist layer and/or function as a planarizing, conformal or via-fill layer. | 11-25-2010 |
20100297557 | Coating compositions suitable for use with an overcoated photoresist - Organic coating compositions, particularly antireflective coating compositions, are provided that can be developed with an aqueous alkaline developer, including in a single step during development of an overcoated photoresist layer. Preferred coating compositions comprise a tetrapolymer that comprises at least four distinct functional groups. | 11-25-2010 |
20110003250 | COATING COMPOSITIONS SUITABLE FOR USE WITH AN OVERCOATED PHOTORESIST - In one aspect, organic coating compositions, particularly antireflective coating compositions, are provided that comprise that comprise a diene/dienophile reaction product. In another aspect, organic coating compositions, particularly antireflective coating compositions, are provided that comprise a component comprising a hydroxyl-naphthoic group, such as a 6-hydroxy-2-naphthoic group Preferred compositions of the invention are useful to reduce reflection of exposing radiation from a substrate back into an overcoated photoresist layer and/or function as a planarizing, conformal or via-fill layer. | 01-06-2011 |
John P. Amara, Charlestown, MA US
Patent application number | Description | Published |
---|---|---|
20090148789 | Coating compositions for use with an overcoated photoresist - In one aspect, the invention relates to silicon-containing organic coating compositions, particularly antireflective coating compositions, that contain a repeat unit wherein chromophore moieties such as phenyl are spaced from Si atom(s). In another aspect, silicon-containing underlayer compositions are provided that are formulated as a liquid (organic solvent) composition, where at least one solvent of the solvent component comprise hydroxy groups. | 06-11-2009 |
20100063225 | Polymer synthetic technique - The present invention generally relates to methods for the synthesis of species including monomers and polymers. Methods of the invention comprise the use of chemical techniques including metathesis chemistry to synthesize, for example, monomers and/or polymers with desired functional groups. | 03-11-2010 |
Rama Amara, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20100040614 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS - PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist. | 02-18-2010 |
20120251537 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS - PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist. | 10-04-2012 |
Rama Amara, Decatur, GA US
Patent application number | Description | Published |
---|---|---|
20100151492 | METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS - PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist. Methods are also disclosed for determining the efficacy of a PD-1 antagonist in a subject administered the PD-1 antagonist. In some embodiments, these methods include measuring proliferation of memory B cells in a sample from a subject administered the PD-1 antagonist. | 06-17-2010 |
20150239972 | METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS - PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist. Methods are also disclosed for determining the efficacy of a PD-1 antagonist in a subject administered the PD-1 antagonist. In some embodiments, these methods include measuring proliferation of memory B cells in a sample from a subject administered the PD-1 antagonist. | 08-27-2015 |
Rama R. Amara, Decatur, GA US
Patent application number | Description | Published |
---|---|---|
20130078276 | VECTORS EXPRESSING HIV ANTIGENS AND GM-CSF AND RELATED METHODS OF GENERATING AN IMMUNE RESPONSE - The disclosure provides vectors encoding one or more HIV antigens and GM-CSF. Also provided are methods of inducing an immune response in a subject, methods of treating a subject having HIV, and methods of manufacturing a medicament for inducing an immune response that require the use of these vectors and vaccine inserts. | 03-28-2013 |
Rama R. Amara, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20150231227 | COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE - Novel plasmid constructs useful for the delivery of DNA vaccines are provided having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses. The constructs are useful for inducing in a patient an immune response against pathogenic viruses such as HIV, measles or influenza. Immunodeficiency virus vaccine inserts of the present invention express non-infectious HIV virus-like particles (VLP) bearing multiple viral epitopes. VLPs allow presentation of the epitopes to multiple histocompatability types. Also described are methods for immunizing a patient by delivery of a novel plasmid of the present invention to a patient. Optionally, the immunization protocol may include a booster vaccination that may be a live vector vaccine such as a recombinant pox virus or modified vaccinia Arbora vector having a transcription cassette expressing the same vaccine insert as the primary immunizing vector. | 08-20-2015 |
Rama Rao Amara, Decatur, GA US
Patent application number | Description | Published |
---|---|---|
20120076820 | CD40L VACCINES, COMPOSITIONS, AND METHODS RELATED THERETO - The disclosure relates to vaccinating a subject against a viral infection, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the use of CD40L expressed on viral like particle as an adjuvant, in combination with a viral antigen, to vaccinate a subject. | 03-29-2012 |
20150231228 | HIV IMMUNE STIMULATING COMPOSITIONS COMPRISING RECOMBINANTLY EXPRESSED PILI ON BACTERIA AND METHODS RELATED THERETO - This disclosure relates to recombinant bacteria, e.g. | 08-20-2015 |
Ryan Amara, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20100198040 | Methods and apparatus for assessing and improving electrode contact with cardiac tissue - Embodiments of the invention relate to methods for assessing and/or improving contact between an electrophysiology catheter and tissue, and catheters for performing the methods. One embodiment relates to a catheter comprising a braided conductive member coupled to the distal end of a shaft, wherein the braided conductive member comprises a plurality of pressure sensitive wires. Another embodiment relates to a catheter comprising a braided conductive member having a plurality of sectors and coupled to the distal end of a shaft, and a balloon assembly constructed and arranged to selectively apply distal pressure to one or more sectors of the braided conductive member. | 08-05-2010 |
20130062523 | DEVICES AND METHODS FOR INFRARED (IR) BASED QUANTITATION OF BIOMOLECULES - The present invention provides methods for quantitating one or more biomolecules in a sample using IR based techniques, sample holder devices for use in such methods as well as methods for manufacturing such sample holder devices. | 03-14-2013 |
20150260621 | IHC, Tissue Slide Fluid Exchange Disposable And System - Apparatus and method for Immunohistochemistry, including a slide holder assembly fixture, a slide holder, a slide holder frame, and a slide holder frame assembly adapted to be placed in communication with a driving force to draw fluid through the slide holder. The slide holder may include an injection port that allows consistent fluid delivery and recovery, while minimizing the introduction of air bubbles. The slide holder may include a reservoir that allows for filling, soaking, rinsing, flushing, uniform antibody coverage of the tissue and reduces handling time, space, and errors, and one or more sample chambers. The slide orientation in the slide holder allows for visualization of label information and tissue to confirm adequate antibody coverage. A multi-port frame allows multiple assays to be carried out concurrently, and is removable from a vacuum manifold and allows for easy transport from the vacuum manifold to an incubator/refrigerator and back. | 09-17-2015 |
Ryan A. Amara, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20120315189 | Immunoassay Product And Process - The embodiments disclosed herein are directed to an apparatus useful in conducting detection of compounds on blotting membranes. The device is comprised of several layers including a porous support layer below the blotting membrane(s), a flow distributor above the blotting membrane(s) and optionally a well on the flow distributor to contain the liquid to the desired area and to allow for lower starting volumes of such liquid. Preferably, the flow distributor is a non-binding or low binding hydrophilic porous membrane such as a 0.22 micron membrane and the support layer is a grid or sintered porous material. The distributor and support are held together to form an envelope around the membrane(s). The use of a hinge, clips and other such devices is preferred in doing so. | 12-13-2012 |